
Oritavancin diphosphate

* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS No. | 192564-14-0 | Cat. No. | BCP24660 |
Name | Oritavancin diphosphate | ||
Synonyms | LY333328 diphosphate; LY-333328 diphosphate; LY 333328 diphosphate; | ||
SMILES | |||
Chemical Name | |||
Formula | C86H103Cl3N10O34P2 | M. Wt | 1989.1 |
Purity | 98% | Storage | Store at 4-8°C |
Description | Oritavancin diphosphate is a novel semisynthetic glycopeptide antibiotic being developed for the treatment of serious Gram-positive bacterial infections.Oritavancin, also known as LY333328, is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci. Oritavancin was more active than either metronidazole or vancomycin against strains of Clostridium difficile tested. Oritavancin has potential use as a therapy for exposure to Bacillus anthracis, the Gram-positive bacterium that causes anthrax, having demonstrated efficacy in a mouse model both before and after exposure to the bacterium. The 4'-chlorobiphenylmethyl group disrupts the cell membrane of Gram-positive bacteria. It also acts by inhibition of transglycosylation and inhibition of transpeptidation. |
Recommend Products
More >
-
-
-
-
-
-
-
-
-
Cephalexin monohydrate
Cat. No.:BCP49078
No.:23325-78-2
Product Details -
Taniborbactam
Cat. No.:BCP36483
No.:1613267-49-4
Product Details -
Cathelicidin LL 37 (human)
Cat. No.:BCP30243
No.:154947-66-7
Product Details -
-
-
Tolfenpyrad
Cat. No.:BCP24108
No.:129558-76-5
Product Details -
Ethoxzolamide
Cat. No.:BCP24088
No.:452-35-7
Product Details -
Grepafloxacin
Cat. No.:BCP23880
No.:119914-60-2
Product Details -
Finafloxacin Hydrochloride
Cat. No.:BCP23879
No.:209342-41-6
Product Details -
Colistimethate Sodium
Cat. No.:BCP15947
No.:8068-37-9
Product Details -
Ampicillin trihydrate
Cat. No.:BCP28578
No.:7177-48-2
Product Details -

Tags:Oritavancin diphosphate supplier,Oritavancin diphosphate purchase,Oritavancin diphosphate manufacturer,Oritavancin diphosphate distributor,Oritavancin diphosphate cost,Oritavancin diphosphate buy,Oritavancin diphosphate for sale